Stock 6547 MEDIGEN VACCINE BIOLOGICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Medigen Vaccine Biologics Corporation

Equities

6547

TW0006547003

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-04-25 EDT 		5-day change 1st Jan Change
51.3 TWD -1.35% Intraday chart for Medigen Vaccine Biologics Corporation +5.77% -26.82%
03-15 Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Medigen Vaccine Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Medigen Vaccine Biologics Corporation Provides License Covid-19 Vaccine to WHO C-TAP and UN Medicines Patent Pool
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Medigen Vaccine Biologics Corporation Withdraws Covid-19 Vaccine Provisional Application and Update with Three-Dose Data for Further Review
Medigen Vaccine Biologics Corporation Approves the Election of Ming-Yi ,Wu as Independent Director and Member of Audit and Remuneration Committees
Medigen Vaccine Biologics Corporation Files New Drug Application of MVC EV71 Vaccine to Drug Administration of Vietnam
Medigen Vaccine Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
Medigen Vaccine Biologics Corporation Announces Board Changes
Medigen Vaccine Biologics Corporation Announces the Resignation of Chang, Ming-Cheng as Independent Director
Medigen Vaccine Biologics Corporation Receives the NDA Approval Letter of Mvcquadrivalent Influenza Vaccine from Taiwan Food and Drug Administration
Medigen Vaccine Biologics Corporation Announces Results of MVC COVID-19 Vaccine Phase 3 Clinical Trial in Thailand
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
MVC File Provisional Approval Application of COVID-19 Vaccine to Therapeutic Goods Administration
Medigen Vaccine Biologics Corporation Announces Update on Clinical Development on MVC Covid-19 Vaccine
Medigen Vaccine Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
Taiwan approves second COVID booster dose, infections yet to peak
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6547 Stock
  4. News Medigen Vaccine Biologics Corporation
  5. Other languages